Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241415. doi: 10.1093/annonc/mdu334.128
|
743TiPAN INTERNATIONAL OBSERVATIONAL STUDY TO ASSESS THE USE OF SORAFENIB AFTER TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): OPTIMIS.
|
Raoul J1, Peck-Radosavljevic M2, Lee HC3, Kudo M4, Nakajima K5, Cheng A6 |
 Author information
1Centre de Lutte Contre le Cancer (CLCC), Institut Paoli-Calmettes, Marseille, FRANCE.
2Department of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AUSTRIA.
3Department of Internal Medicine, Asan Medical Center, Seoul, KOREA.
4Gastroenterology and Hepatology, Kinki University Hospital, Osaka, JAPAN.
5Global Medical Affairs, Bayer Healthcare Pharmaceuticals, Whippany, NJ, USA.
6Oncology, National Taiwan University Hospital, Taipei, TAIWAN.
|
Publikations ID: 28171929
Quelle: öffnen
|